Pharmacokinetics of the doxorubicin magnetic nanoconjugate in mice. Effects of the nonuniform stationary magnetic field

Ukrain'skyi Biokhimichnyi Zhurnal

Volumn 77, Issue 5, 2005, Pages 80-92

  Mykhaylyk, O M ^a   Dudchenko, N O ^a   Dudchenko, A K ^a  

^a Department of Quantum Electronics   (Ukraine)

Author keywords

Conjugate; Electron spin resonance; Magnetic drug targeting, doxorubicin (adriamycin); Non uniform stationary magnetic field; Pharmacokinetics

Indexed keywords

DOXORUBICIN; DRUG CARRIER; MAGNETITE; NANOMATERIAL;

ANIMAL; ARTICLE; BIOAVAILABILITY; CELL SURVIVAL; DRUG EFFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; BIOLOGICAL AVAILABILITY; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG CARRIERS; FERROSOFERRIC OXIDE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MICE; NANOSTRUCTURES; TISSUE DISTRIBUTION;

EID: 32344449861     PISSN: 02018470     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dunkan R., Dimitoijevic S., Evagaron E. G. // STP Pharma. Sci. - 1996. - 6. - P. 237-263.
2. Lefrak E.A., Ritha J., Rosenheim S. // Cancer. - 1973. - 32. - P. 302-314.
3. Couvreur P., Kante B., Grislain L. et al. // J. Pharm. Sci. - 1982. - 71. - P. 790-792.
4. Mosbach K., Schröder U. // FEBS Letters. - 1979. - 102. - P. 112-116.
5. Pankhurst Q. A., Connolly J., Jones S. K. et. al. // J. Phys. D.: Appl. Phys. - 2003. - 36. - R167-R181.
6. Senyei K., Widder K., Czerlinski G. // J. Appl. Phys. - 1978. - 49. - P. 3578-3583.
7. Ruuge E. K., Rusetski A. N. // J. Magn. Magn. Mater. - 1993. - 122. - P. 335-339.
8. Renkin E. M. // Circ. Res. - 1978. - 41. - P. 735.
9. Seymour L. W. // Crit. Rev. Ther. Drug. Carrier Syst. - 1992. - 9. - P. 135-187.
10. Yuan F., Dellian M., Fukumura D. et al. // Cancer Research. - 1995. - 55. - P. 3752-3756.
11. Scholten P. S., Felius J. A. P. // J. Magn. Magn. Mater. - 1990. - 85. - P. 107.
12. Krueger D. A. // IEEE Trans. Magn. Mag. - 1980. - 16. - P. 251.
13. Mykhaylyk O., Kotzuruba A., Buchanevich A. et. al. // J. Mang. Magn. Mater. - 2001. - 225. - P. 226-234.
14. Cornell R. M., Schwertmann U. The Iron Oxides: Structure, Properties, Reactions, Occurrences and Uses. - Weinheim: Wiley-VCH, 2003. - 703 p.
15. Verdun C., Brasseur F., Vranckx H. et al. // Cancer Chemother. Pharmacol. - 1990. - 26. - P. 13-18.
16. Lightfoot E. N. Transport phenomena in living systems. Biomedical aspects of momentum and mass transport. - New York: Willey & Sons, 1974. - 253 p.
17. Yuan F., Salehi H. A., Boucher Y. et al. // Cancer research. - 1994. - 54. - P. 4564-4568.
18. Mykhayfyk O. M, Dudchenko A. K, Pridatchenko Yu. V. et al. // Dopovidi Acad. Nauk Ukrainy, - 1998. - N 11. - P. 92-96.
19. Chen H. S., Gross J. F. // Cancer. Treat. Rep. - 1980. - 64. - P. 31-40
20. Widder K. J., Senyei A., Scarpelli D. G.// Proc. Soc. Exp. Biol. Med. - 1978. - 58. - P. 141-146.
21. Lübbe A. S., Alexiou C., Bergemann C. // J. Surg. Res. - 2001. - 95. - P. 200-206.
22. Hafeli U. O., Sweeney S. M., Beresford B. A. et al. // Nucl. Med. Biol. - 1995. - 22. - P. 147-55.
23. Viroonchatapan E., Sato H., Ueno M. et al. // Life Sci. - 1996. - 58. - P. 2251-61.
24. Sabo J., Mirossay L., Hrovcak L, et al. // Bioelectrochemistry. - 2002. - 56. -P. 227-231.
25. Flipo D., Fournier M., Benquet C. et al. // J. Toxicol. Environ. Health. - 1998. - A 54. - P. 63-76.